Stella Logotheti

888 total citations
33 papers, 671 citations indexed

About

Stella Logotheti is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stella Logotheti has authored 33 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Stella Logotheti's work include Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (3 papers). Stella Logotheti is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (3 papers). Stella Logotheti collaborates with scholars based in Germany, Greece and Türkiye. Stella Logotheti's co-authors include Vassilis Zoumpourlis, Brigitte M. Pützer, Vassilis G. Gorgoulis, Stephan Marquardt, Spiros Vlahopoulos, Dimitrios Delakas, Αlex Galanis, Tanya Kadiyska, Dimitrios Volanis and Athanasia Pavlopoulou and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Stella Logotheti

32 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella Logotheti Germany 16 416 212 198 75 65 33 671
Yu Ma China 15 337 0.8× 199 0.9× 245 1.2× 85 1.1× 43 0.7× 36 679
Lorenzo Bombardelli Netherlands 9 375 0.9× 168 0.8× 166 0.8× 39 0.5× 93 1.4× 13 637
Shengguang Yuan China 15 469 1.1× 231 1.1× 259 1.3× 61 0.8× 101 1.6× 21 728
Qingqu Guo China 14 326 0.8× 247 1.2× 146 0.7× 92 1.2× 76 1.2× 27 613
Maria Serena Roca Italy 14 457 1.1× 184 0.9× 152 0.8× 36 0.5× 104 1.6× 28 709
Baoen Shan China 15 296 0.7× 173 0.8× 158 0.8× 63 0.8× 66 1.0× 46 516
Xiaojun Yang China 13 539 1.3× 403 1.9× 406 2.1× 71 0.9× 77 1.2× 28 944
Mingsong Wang China 17 549 1.3× 106 0.5× 284 1.4× 53 0.7× 56 0.9× 33 761
Aline Hébrant Belgium 14 496 1.2× 241 1.1× 286 1.4× 39 0.5× 96 1.5× 24 895

Countries citing papers authored by Stella Logotheti

Since Specialization
Citations

This map shows the geographic impact of Stella Logotheti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Logotheti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Logotheti more than expected).

Fields of papers citing papers by Stella Logotheti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Logotheti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Logotheti. The network helps show where Stella Logotheti may publish in the future.

Co-authorship network of co-authors of Stella Logotheti

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Logotheti. A scholar is included among the top collaborators of Stella Logotheti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Logotheti. Stella Logotheti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Logotheti, Stella, Athanasia Pavlopoulou, Anne-Marie Galow, et al.. (2024). Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: the paradigm of radiotherapy. Pharmacology & Therapeutics. 260. 108670–108670. 2 indexed citations
2.
Küçük, Can, Alexandros G. Georgakilas, Bernhard M. Stadler, et al.. (2024). Computer-Aided Identification and Design of Ligands for Multi-Targeting Inhibition of a Molecular Acute Myeloid Leukemia Network. Cancers. 16(21). 3607–3607. 1 indexed citations
3.
Singh, Nivedita, Faiz M. Khan, Julio Vera, et al.. (2023). Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression. BMC Chemistry. 17(1). 161–161. 2 indexed citations
4.
Nikitaki, Zacharenia, Christine E. Hellweg, Edouard I. Azzam, et al.. (2022). Radiation Type- and Dose-Specific Transcriptional Responses across Healthy and Diseased Mammalian Tissues. Antioxidants. 11(11). 2286–2286. 13 indexed citations
5.
Brinkmeier, Heinrich, Stella Logotheti, Anika Jonitz‐Heincke, et al.. (2022). Novel integrated workflow allows production and in-depth quality assessment of multifactorial reprogrammed skeletal muscle cells from human stem cells. Cellular and Molecular Life Sciences. 79(5). 229–229. 4 indexed citations
6.
Logotheti, Stella, et al.. (2022). p73 isoforms meet evolution of metastasis. Cancer and Metastasis Reviews. 41(4). 853–869. 6 indexed citations
7.
Logotheti, Stella, et al.. (2021). Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond. Frontiers in Cell and Developmental Biology. 9. 737735–737735. 19 indexed citations
8.
9.
Logotheti, Stella, Stephan Marquardt, Shailendra K. Gupta, et al.. (2020). LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1. Theranostics. 10(21). 9620–9643. 71 indexed citations
10.
Marquardt, Stephan, Fanghua Li, Alf Spitschak, et al.. (2019). Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness. Journal of Experimental & Clinical Cancer Research. 38(1). 292–292. 17 indexed citations
11.
Gupta, Shailendra K., David Engelmann, Alf Spitschak, et al.. (2019). Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers. Theranostics. 9(5). 1490–1509. 16 indexed citations
12.
Logotheti, Stella, Alf Spitschak, Stephan Marquardt, et al.. (2018). DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression. Cancer Letters. 442. 299–309. 22 indexed citations
13.
Nekulová, Marta, Jitka Holčáková, Xiaolian Gu, et al.. (2016). ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells. BMC Cancer. 16(1). 782–782. 19 indexed citations
14.
Logotheti, Stella, Athanasia Pavlopoulou, Andreas Scorilas, et al.. (2016). Unravelling a p73-regulated network: The role of a novel p73-dependent target, MIR3158, in cancer cell migration and invasiveness. Cancer Letters. 388. 96–106. 17 indexed citations
15.
Logotheti, Stella, Spiros Vlahopoulos, Triantafillos Liloglou, et al.. (2016). N-bromotaurine surrogates for loss of antiproliferative response and enhances cisplatin efficacy in cancer cells with impaired glucocorticoid receptor. Translational research. 173. 58–73.e2. 7 indexed citations
16.
Logotheti, Stella, et al.. (2013). Functions, divergence and clinical value of TAp73 isoforms in cancer. Cancer and Metastasis Reviews. 32(3-4). 511–534. 25 indexed citations
17.
Logotheti, Stella, Ioannis Michalopoulos, Maria Sideridou, et al.. (2012). Progression of Mouse Skin Carcinogenesis Is Associated with Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα. PLoS ONE. 7(8). e41957–e41957. 10 indexed citations
18.
Logotheti, Stella, Ioannis Michalopoulos, Maria Sideridou, et al.. (2010). Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73γ in lung cancer. FEBS Journal. 277(14). 3014–3027. 17 indexed citations
19.
Logotheti, Stella, George Xinarianos, John R. Gosney, et al.. (2010). Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer. Cancer Letters. 300(1). 79–86. 41 indexed citations
20.
Vlahopoulos, Spiros, et al.. (2008). The role of ATF‐2 in oncogenesis. BioEssays. 30(4). 314–327. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026